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Coagulase-negative staphylococci differ phenotypically 
from Staphylococcus aureus by lacking the ability to form 
some extracellular products and cell wall-associated 
proteins [l]. In routine clinical microbiology the 
coagulase test-tube reaction has been used as the main 
species characteristic of S. auretcs [l], as has DNase 
formation in food microbiology [2]. Although less 
sensitive and less specific than coagulase formation [3],  
the demonstration of clumping factor is often used in 
routine clinical microbiology. The clumping factor of 
S.  uureus is a cell wall-associated protein which reacts 
with fibrinogen monomers, thus leading to aggregation 
of S. arireiis cells [4]. The recent emergence of epidemic 
methicillin-resistant S.  aureus (MRSA) lacking this 
capability [5] has rendered tests based only on the 
demonstration of protein agglutination unreliable [6]. 
Therefore, recently developed test kits have included 
the use of antibodies against cell wall-associated macro- 
molecules, and IgG specific for S. arireus protein A [7]. 
This communication reports on the sensitivity and 
specificity of the Dry Spot Staphytect Plus test (Oxoid, 
Basingstoke, UK) and three other agglutination tests for 
speciating staphylococcal species, especially S.  aureus 
including methicillin-resistant isolates. 
For methicillin-sensitive S. aureus (MSSA, tz= 130), 
strains belonging to the major clonal group of this 
species as deduced from genomic DNA fragment 
patterns [8] were tested. For MRSA (n=8O), five 
isolates from each of six MRSA epidemics with an 
inter-regional dissemination in Germany [9] were 
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included, and in addition 50 isolates which, according 
to their Snid macrorestriction patterns, are different to 
both each other and these epidemic strains. All S. aur~'i{s 
strains included in the study were isolated from human 
sites of infection. 
All S. oi(wus strains involved in this study produced 
coagulase and gave an expected 423-bp P C R  product 
specific for the ribosonial RNA spacer region [lo]. 
In addition, 100  coagulase-negative staphylococci 
(CNS) were included in the study: S. epidcrrnidis (50), 
S. Iiaernolytims (35), S. lioruirzk ( 6 ) ,  S. sirizrilans (l), 
S. airviciilaris ( l ) ,  S. sciriri (l), S. capitis (4), S. kloosii (a), 
S.  u~oiv ic~i  (a), S. sciiic~f;.ri (2),  S. c-ohi i  (I), and S. XYlOSUS 
(5). All strain? were speciated by classical biochemical 
methods [3] and originated from human sites of in- 
fection or colonization. 
The following agglutination tests have been coni- 
pared: Staphyslide-Test (bioMPrieux, Marcy I'Etoile, 
France), composed of fibrinogen bound to red blood 
cells; Pastorex Staph-Plus (Sanofi, Marne-LaCoguette, 
Frmce), composed of latex coated with fibrinogen, 
IgC and antibodies against capsular polysaccharides; 
Staphaurex Plus (Murex Diagnostics Ltd, Dartford, 
UK),  coniposed of fibrinogen as well as antibodies 
against serotype 5 c'ipsular polysaccharides and somatic 
type 18 bound to latex; and Dry Spot Staphytect Plus 
(Oxoid Ltd, Basingstoke, UK), composed of latex 
pxticles coated with pig fibrinogen, IgG and anti- 
bodies to capsular polysaccharides dried on the surface 
of smooth pasteboard. All tests were performed as 
recommended by the manufacturers. S. O I I Y C I I . ~  species 
type WAS confirmed by PCK of ribosonial R N A  gene 
sequences specific for S. aiiwta. Whole cellular DNA 
was isolated as described previously [l  11. Primers used 
were SA V (5'CATATTGTATTCAGTTTTGA-3') 
and SA VI (5'-TCCACCATTTTTATAACTC-3') 
[ 1 ( '1. Replithern-polymerase (Biozyni, Markoldendorf, 
Germany) and reaction mixtures as previously described 
11 11 were used with the following DNA aniplification 
conditions: 30 cycles of 94OC for 1 niin, 55°C for 2 
niin, and 72OC for 3 min. 
For the demonstration of free coagulase using the 
test-tube method, five colonies were suspended in 0.5 
niL of Oxoid nutrient broth. After incubation for 2 h 
at 37OC. 0.5 inL ofhunian blood plasma was added. The 
tubes were inspected for formation of clots after 3 h <it 
37OC and again after 24 h a t  room temperature. For 
detection of clumping factor, one colony from a blood 
agar plate (incubated overnight) was picked with a 
sterile loop, suspended on a glass slide in approximately 
30 pL of0.9"% NaCl solution and mixed with approxi- 
mately 70 pL of human fibrinogen solution (2 nig/niL 
in 0.90,; NaCl). Results of the comparison of different 
agglutination tests with the tube coagulase and cluniping 
factor are shown in Table 1). For all four tests, the 
sensitivity for detecting MSSA was 1 UOi%. 
As is evident froni the results obtained with the 
Staphyslide-Test, tests designed only for the detection 
of clumping factor are highly specific but not sensitive 
enough for correct detection of MRSA, in contrast to 
the increased sensitivity of test kits containing addi- 
tional coiiiponents such as IgG and antibodies against 
capsular polysaccharides. For Staphaurex Plus and for 
Pastorex Staph-Plus a high sensitivity for identification 
Table 1 Coinparison of different test kits for rapid didpotis of Stqdqhcorc i r s  species 
Dry Spot Pastorex Staphaurex Staphytlidc- Clumping Tubc 
Staphytect Plur St.1ph-Plus Plus Test r e x  tion co.lgul'l\c 
MSSA, ! I =  1 3 1  
Negative 
Intrrrnediatc 
Po\ltlve 
MKSA, ir=80 
Negative 
Intrrir~cdiate 
Positive 
CNS, i t =  1 0 0  
N e g ~  tivr 
Interinedi~itr 
I'osi tive 
Scllcltlvltlv ("0) 
Specificity ("{I) 
- 
- 
120 
21 
5 
54 
90 
1 
- 
87 
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of MRSA has been previously reported [6]. The 
specificity of these test kits is only slightly reduced with 
regard to a positive reaction of S. schlegeferi (Dry Spot 
Staphytect Plus) and S. sckleferi and S. cohnii (Pastorex 
Staph-Plus, Staphaurex Plus). 
For S. schleij%ri a positive clumping reaction has 
been described when suspended in human blood 
plasma [12]. The absence of clumping in fibrinogen 
solution (Table 1) suggests that S. schleiferi probably 
possesses another surface component as well as the 
clumping factor, reacting with plasma constituents 
other than fibrinogen. 
Of the 80 MRSA strains, five gave intermediate 
results with tests based on demonstration of clumping 
factor alone, which may be due to weak expression of 
clumping factor. One strain was also intermediate 
when Dry Spot Staphytect Plus or Staphaurex Plus 
were used. These intermediate reactions were also 
found when isolates were retested following fresh 
subculture on blood agar. In clinical bacteriology the 
coagulase tube test should be performed for strains 
which are intermediate in agglutination tests. The few 
CNS exhibiting intermediate agglutination reactions 
were identified as S. epidermidis isolates and originated 
from blood cultures. The bases for this reaction are 
unknown. 
In conclusion, Dry Spot Staphytect Plus has an 
excellent sensitivity for the identification of S. uclreus in 
the clinical microbiology laboratory. 
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